Suppr超能文献

预测动脉瘤性蛛网膜下腔出血患者两个月改良 Rankin 量表的有序预测模型。

Prediction of two month modified Rankin Scale with an ordinal prediction model in patients with aneurysmal subarachnoid haemorrhage.

机构信息

Department of Medical Informatics, Erasmus MC, Rotterdam, the Netherlands.

出版信息

BMC Med Res Methodol. 2010 Sep 29;10:86. doi: 10.1186/1471-2288-10-86.

Abstract

BACKGROUND

Aneurysmal subarachnoid haemorrhage (aSAH) is a devastating event with a frequently disabling outcome. Our aim was to develop a prognostic model to predict an ordinal clinical outcome at two months in patients with aSAH.

METHODS

We studied patients enrolled in the International Subarachnoid Aneurysm Trial (ISAT), a randomized multicentre trial to compare coiling and clipping in aSAH patients.Several models were explored to estimate a patient's outcome according to the modified Rankin Scale (mRS) at two months after aSAH. Our final model was validated internally with bootstrapping techniques.

RESULTS

The study population comprised of 2,128 patients of whom 159 patients died within 2 months (8%). Multivariable proportional odds analysis identified World Federation of Neurosurgical Societies (WFNS) grade as the most important predictor, followed by age, sex, lumen size of the aneurysm, Fisher grade, vasospasm on angiography, and treatment modality. The model discriminated moderately between those with poor and good mRS scores (c statistic = 0.65), with minor optimism according to bootstrap re-sampling (optimism corrected c statistic = 0.64).

CONCLUSION

We presented a calibrated and internally validated ordinal prognostic model to predict two month mRS in aSAH patients who survived the early stage up till a treatment decision. Although generalizability of the model is limited due to the selected population in which it was developed, this model could eventually be used to support clinical decision making after external validation.

TRIAL REGISTRATION

International Standard Randomised Controlled Trial, Number ISRCTN49866681.

摘要

背景

动脉瘤性蛛网膜下腔出血(aSAH)是一种破坏性事件,常导致残疾。我们的目的是建立一个预后模型,以预测 aSAH 患者两个月时的序贯临床结局。

方法

我们研究了国际蛛网膜下腔动脉瘤试验(ISAT)中纳入的患者,这是一项比较 aSAH 患者血管内弹簧圈栓塞和开颅夹闭的随机多中心试验。我们探索了几种模型来根据改良 Rankin 量表(mRS)评估患者在 aSAH 后两个月的结局。我们的最终模型通过自举技术进行了内部验证。

结果

研究人群包括 2128 名患者,其中 159 名患者在 2 个月内死亡(8%)。多变量比例优势分析确定世界神经外科学会联合会(WFNS)分级是最重要的预测因素,其次是年龄、性别、动脉瘤管腔大小、Fisher 分级、血管造影时的血管痉挛和治疗方式。该模型在 mRS 评分较差和较好的患者之间有适度的区分(c 统计量=0.65),根据自举重采样有轻微的乐观倾向(校正后的 c 统计量=0.64)。

结论

我们提出了一个校准和内部验证的序贯预后模型,以预测早期存活至治疗决策阶段的 aSAH 患者两个月时的 mRS。尽管由于该模型在特定人群中开发,其推广性有限,但该模型最终可以在外部验证后用于支持临床决策。

试验注册

国际标准随机对照试验,编号 ISRCTN49866681。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0937/2955659/cc056d3c1718/1471-2288-10-86-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验